Jm. Yang et A. Richmond, Constitutive I kappa B kinase activity correlates with nuclear factor-kappa B activation in human melanoma cells, CANCER RES, 61(12), 2001, pp. 4901-4909
Constitutive IKK activity associated with increased I kappaB alpha phosphor
ylation and degradation contribute to the high level of endogenous nuclear
factor-kappaB (NF-kappaB) activation in Hs294T melanoma cells as compared w
ith RPE cells (R. L. Shattuck-Brandt and A. Richmond, Cancer Res., 57: 3032
-3039, 1997; M. N. Devalaraja et al., Cancer Res., 59: 1372-1377, 1999). To
determine whether this endogenous NF-kappaB activation was characteristic
of melanoma, we examined the level of constitutive activation of NF-kappaB
in a number of melanoma cell lines. We demonstrate here that eight melanoma
cell lines exhibit increased I kappaB kinase (IKK) activity, enhanced phos
phorylation of I kappaB alpha and p65, and enhanced nuclear localization of
p65/p50 in comparison to normal human epidermal melanocytes. The chemokine
s, CXC ligand 1 (CXCL1) and CXCL8, but not CXCL5, are highly expressed in m
ost of the melanoma cell lines, suggesting that the constitutive production
of chemokines is highly correlated to endogenous NF-kappaB activity. Our f
ailure to observe a direct relationship between the fold activation of IKK,
CXCL1, or CXCL8 mRNA levels and secretion of these chemokines into the cul
ture medium suggest that regulation of chemokine expression also occurs at
the posttranscription level of mRNA stability and/or translational control.
Moreover, recombinant CXCL1 can directly induce IKK activity in normal hum
an epidermal melanocytes in a concentration-dependent manner after up-modul
ation of CXCL1 protein expression, whereas inhibition of IKR beta activity
results in down-modulation of CXCL1 protein expression. Finally, CXCL1 anti
body blocks IKK activity and inhibits the proliferation of melanoma cells t
o further support the concept that the constitutive activation of NF-kappaB
and autocrine effects of CXCL1 play an important role in the pathogenesis
of melanoma.